Open AccessCorrection: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients
Author(s) -
Lihui Qu,
Yingying Lu,
Meike Ying,
Bingjue Li,
Chunhua Weng,
Zhoutao Xie,
Ludan Liang,
ChingLong Lin,
Xiàn Yáng,
Shi Feng,
Yucheng Wang,
Xiaohua Shen,
Qin Zhou,
Ying Chen,
Zhimin Chen,
Jiang Wu,
Weiqiang Lin,
Yi Shen,
Jing Qin,
Hang Xu,
Feng Xu,
Junwen Wang,
Jianghua Chen,
Hong Jiang,
Hongfeng Huang
Publication year - 2020
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.27561
Subject(s) - tacrolimus , medicine , renal transplant , cyp3a5 , genotype , pharmacogenetics , oncology , bioinformatics , pharmacology , transplantation , urology , biology , genetics , gene
[This corrects the article DOI: 10.18632/oncotarget.18150.].